Abstract
4SCAR2.0 Treating Refractory B Cell Lymphomas: An advanced Technology Saves More Lives!
CAR-T cell therapy represents an innovative and effective therapy forpatientswithrefractory/relapsed Bcellmalignancies. However, many limitations remain with the currently approved CAR-T products, including antigen escape, CAR-T exhaustion in vivo, significant toxicity, and high cost, to name a few.
Author(s):
Cheng Jiao, Liyuan Sheng and Lung-Ji Chang
Abstract | Full-Text | PDF
Share this
Awards Nomination
Google scholar citation report
Citations : 230
Medical Case Reports received 230 citations as per google scholar report
Medical Case Reports peer review process verified at publons
Abstracted/Indexed in
- Google Scholar
- China National Knowledge Infrastructure (CNKI)
- Cosmos IF
- Directory of Research Journal Indexing (DRJI)
- WorldCat
- Publons
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences